Battery Management Corp’s Champions Oncology CSBR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Hold
2,421,673
3.27% 5
2025
Q4
$16.7M Hold
2,421,673
2.69% 5
2025
Q3
$15.7M Hold
2,421,673
2.99% 4
2025
Q2
$17.8M Hold
2,421,673
3.14% 4
2025
Q1
$21M Hold
2,421,673
3.06% 5
2024
Q4
$20.8M Hold
2,421,673
2.66% 5
2024
Q3
$11.8M Hold
2,421,673
3.63% 4
2024
Q2
$12.5M Hold
2,421,673
3.29% 4
2024
Q1
$11.9M Hold
2,421,673
2.62% 4
2023
Q4
$13.6M Hold
2,421,673
2.43% 4
2023
Q3
$15M Hold
2,421,673
3.94% 4
2023
Q2
$15.5M Hold
2,421,673
3.19% 5
2023
Q1
$9.74M Hold
2,421,673
1.4% 6
2022
Q4
$10.9M Hold
2,421,673
2% 7
2022
Q3
$18.2M Hold
2,421,673
3.11% 6
2022
Q2
$19.4M Hold
2,421,673
3.21% 6
2022
Q1
$19.7M Hold
2,421,673
3% 7
2021
Q4
$20.2M Hold
2,421,673
2.73% 7
2021
Q3
$24.7M Hold
2,421,673
1.15% 8
2021
Q2
$24.9M Hold
2,421,673
1.39% 7
2021
Q1
$27.4M Hold
2,421,673
3.49% 6
2020
Q4
$26.1M Buy
+2,421,673
New +$25M 6.61% 4

Other funds holding CSBR

Battery Management Corp's CSBR Position: Q1 2026 in Review

Battery Management Corp held its Champions Oncology (CSBR) position steady in Q1 2026 at 2,421,673 shares worth $13.9M. The position accounts for 3.27% of the portfolio, ranked #5.

Battery Management Corp first reported a position in CSBR in Q4 2020 and has held it in 22 quarters since. The position peaked at $27.4M in Q1 2021. 25 funds tracked by Wall St. Rank hold CSBR as of Q1 2026.

  • Battery Management Corp held 2,421,673 shares of Champions Oncology worth $13.9M as of Q1 2026.
  • Battery Management Corp left its Champions Oncology share count unchanged in Q1 2026.
  • Champions Oncology made up 3.27% of Battery Management Corp's portfolio in Q1 2026, its #5 holding.
  • Battery Management Corp first reported a position in Champions Oncology in Q4 2020 and has held it in 22 quarters since.
  • Battery Management Corp's Champions Oncology position peaked at $27.4M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2026.

Based on Battery Management Corp's 13F filing for Q1 2026, filed 15 May 2026.